NCT06041997

Brief Summary

The goal of this clinical trial is to study smartphone use restriction as a treatment modality in patients of primary headache. The main question\[s\] it aims to answer are:

  1. 1.In patients with primary headache, does restriction of smartphone use lead to reduced consumption of medications (acute, prophylaxis, either or both)?
  2. 2.In patients with primary headache, does restriction of smartphone use lead to better responsiveness to medications (acute, prophylaxis, either or both)?
  3. 3.Can reduction of smartphone duration be used as a non-pharmacological treatment of primary headache?
  4. 4.In patients with primary headache, is the type of smartphone use (phone calls, internet browsing, watching screen) determinant of the severity of headache?
  5. 5.Can we make an addiction score to predict which patient should be advised to limit smartphone use based on the above information?
  6. 6.In patients with primary headache, does restriction of smartphone use led to improvement in headache severity (frequency, intensity, duration, one of them or all).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Oct 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress82%
Oct 2023Nov 2026

First Submitted

Initial submission to the registry

September 12, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 18, 2023

Completed
13 days until next milestone

Study Start

First participant enrolled

October 1, 2023

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2026

Last Updated

December 2, 2024

Status Verified

November 1, 2024

Enrollment Period

3 years

First QC Date

September 12, 2023

Last Update Submit

November 28, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • The pill burden for abortive treatment

    The number of times the patient is using acute pain medications for headache in one month

    three months after initiation of study period

Secondary Outcomes (2)

  • Headache frequency

    One and three months

  • Number of prophylactic medication

    Three months

Study Arms (2)

Smartphone restriction

EXPERIMENTAL

Patients with headache with history of high smartphone use will be randomized into restriction and no-restriction arm. Restriction method: In the 'run-in' period of four weeks, the smartphone usage will be assessed in terms of number of overall use. The patients will then be advised to cut down the usage by one-third in terms of usage hours. The compliance will be checked at the time of outcome assessment.

Behavioral: Smartphone restriction

Control

NO INTERVENTION

Comparison: In the 'run-in' period of four weeks, the smartphone usage will be assessed in terms of number of overall use. In the non-intervention group only the smartphone usage data will be collected in the study period. The non-smartphone users will be as another control arm.

Interventions

The patients will then be advised to cut down the usage by one-third in terms of usage hours. The compliance will be checked at the time of outcome assessment.

Smartphone restriction

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients ≥18 years of age
  • Diagnosis of primary headache as per the ICHD3Beta classification ("ICHD-3 The International Classification of Headache Disorders 3rd Edition" n.d.)
  • Willing and consenting to participate in the study.

You may not qualify if:

  • \. Secondary headaches 2. Not consenting for participation or follow up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Deepti Vibha

New Delhi, National Capital Territory of Delhi, 110029, India

RECRUITING

MeSH Terms

Conditions

Headache Disorders

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Deepti Vibha

    All India Institute of Medical Sciences

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Rajesh Singh

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

September 12, 2023

First Posted

September 18, 2023

Study Start

October 1, 2023

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

November 30, 2026

Last Updated

December 2, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will share

Anonymized data will be shared on reasonable request

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
After the completion of the publication for six months
Access Criteria
Shared on individual request

Locations